EMEA-001212-PIP01-11
Key facts
Invented name |
Kineret
|
Active substance |
anakinra
|
Therapeutic area |
Immunology-Rheumatology-Transplantation
|
Decision number |
P/0066/2012
|
PIP number |
EMEA-001212-PIP01-11
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Subcutaneous use
|
Contact for public enquiries |
Swedish Orphan Biovitrum AB
|
Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|
Compliance procedure number |
EMEA-C-001212-PIP01-11
|
Compliance opinion date |
12/12/2014
|
Compliance outcome |
positive
|